MIGAL’s female researcher Dr. Dorit Avni, awarded 7.5 million grant for ground-breaking research into inflammatory bowel disease

Dr. Dorit Avni was only one of the MIGAL’s female researchers who participated in the Researchers Course “Champions” for the advancement of women researchers. A course that MIGAL, Galilee Research Institute (MIGAL) a regional mega-R&D centre supported by Israel’s Ministry of Science and Technology, launched in 2019 for improving gender equality in research, thanks to the Gender Equality Plan developed in the framework of the R&I Peers project. The course had the objective to promote women’s participation in international and competitive research projects, in leading scientific journals, and participate in economic and research decision-making. The course tacked aspects like, empowering self-confidence, improving presentation capabilities and the ability to write competitive research proposal.

Dr. Dorit Avni from the MIGAL Galilee Research Institute receives the prestigious Horizon 2020 R&D grant.
(photo credit: MIGAL RESEARCH INSTITUTE)
Dr. Dorit Avni from the MIGAL Galilee Research Institute receives the prestigious Horizon 2020 R&D grant, February 7, 2021. (photo credit: MIGAL RESEARCH INSTITUTE)

As a result, Dr. Dorit Avni,the group leader of MIGAL’s Bioactive Metabolites and Immune Modulation Laboratory, initiated, led and coordinated ALGEA4IBD, a project, that has been now awarded the prestigious European Union HORIZON 2020 R&D grant in the amount of EUR 7.5 million.

Shai-Lee Spigelman, Science and Technology Ministry Director-General complimented her and her team by saying “This award is an impressive achievement that few achieve, with international recognition confirming the importance of this innovative project aimed at transforming algae into sorely needed treatments for inflammatory related diseases.”

For more details see the article published in Yahoo Finance or The Jerusalem Post.